Brought to you by:
Healthcare on a precipice: SVS PAC stands ready to fight coming challenges
Since 2002, the SVS Political Action Committee (PAC) has been a vehicle for advocacy specifically for vascular surgeons. As the only voice geared for vascular surgeons in Washington, D.C., it plays an instrumental role in championing pressing concerns that matter…
VOYAGER PAD: Rivaroxaban plus aspirin versus aspirin alone among CLTI patients undergoing revascularization reduced risk of adverse outcomes at three years
In one of the latest sub-analyses from the VOYAGER PAD trial, investigators found that rivaroxaban plus aspirin versus aspirin alone in the high-risk population of patients with critical limb-threatening ischemia (CLTI) undergoing lower-extremity revascularization reduced the risk of a first…
SVS members in the news
Richard Lynn, MD, a vascular surgeon from Palm Beach, Florida, has been elected second vice-president-elect of the American College of Surgeons (ACS). Alan Dardik, MD, of Yale University School of Medicine, New Haven, Connecticut, and Andres Schanzer, MD, of the…
Dig deep this Giving Tuesday
Will you give on Giving Tuesday? This will be the SVS Foundation’s third year marking the annual global day of giving—Dec. 1, this year—which follows Thanksgiving and the big shopping days of Black Friday and Cyber Monday. The day is…
Diabetes Awareness Month: The utility of SVS branding fliers for diabetic foot ulcers
November is Diabetes Awareness Month. The Branding Toolkit can help SVS members promote the valuable care they provide those with the disease. One of the three customizable condition fliers currently available covers diabetic foot ulcers (the other two address abdominal…
SVS details opposition, support to CMS proposed rules
The Society for Vascular Surgery (SVS) has submitted comment letters to the Centers for Medicare & Medicaid Services (CMS) on two proposed rules that directly affect SVS members: the Medicare Physician Fee Schedule and the Hospital Outpatient Prospective Payment and…
Previously described patient-centered clinical success measure after revascularization for diabetic foot wounds may be ‘too strict’
Patient-centered clinical success after lower-extremity revascularization for people with diabetic foot wounds was achieved among 63% of patients in a new analysis—but researchers suggest the measure on which the study was based may define clinical success too strictly given the…
DETOUR I two-year outcomes: ‘Excellent’ functional improvement in complex PAD cohort
During a late-breaking data session at this year’s Vascular Interventional Advances virtual annual meeting (VIVA 2020) Nov 6–8, Ehrin Armstrong, MD, a professor of cardiology at the University of Colorado, Denver, presented two-year outcomes from the DETOUR I trial for…
Abstracts for VRIC, VAM 2021
Calling surgeons and scientists: Your research is wanted. Submission sites are now open for two annual SVS meetings in 2021, the Vascular Research Initiatives Conference (VRIC) and the Vascular Annual Meeting (VAM). The VRIC submission site will close Jan. 6,…
Case study: Putting the SVS Branding Toolkit into action
William Shutze, MD, a member in community practice in Dallas, has lost no time in putting the new SVS Branding Toolkit to use. In fact, he was experimenting with it during the SVS Town Hall in mid-September at which it…